The REBORN project will aim to use smart and multifunctional biomaterial to deliver a new medical device in the form of a cardiac patch, to be applied to the heart to stimulate and support local heart tissue remodelling after episodes of myocardial infraction. The piezoelectric path will deliver anti-inflammatory, anti-fibrotic and cardiomyocyte proliferative factors on demand, with drug release triggered by ultrasonic simulation from outside of the body.

We are pleased to announce the launch of the official video for the project, where Santorini Scientific is participating to help the 2 million people in Europe affected by heart disease every year. Take a look at how our consortium of European companies and universities is tacking myocardial infraction with innovative solutions.